IL166108A0 - Novel compounds pharmaceutical compositions containing same and methods of use for same - Google Patents
Novel compounds pharmaceutical compositions containing same and methods of use for sameInfo
- Publication number
- IL166108A0 IL166108A0 IL16610805A IL16610805A IL166108A0 IL 166108 A0 IL166108 A0 IL 166108A0 IL 16610805 A IL16610805 A IL 16610805A IL 16610805 A IL16610805 A IL 16610805A IL 166108 A0 IL166108 A0 IL 166108A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- methods
- pharmaceutical compositions
- compositions containing
- novel compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39458502P | 2002-07-09 | 2002-07-09 | |
PCT/US2003/021700 WO2004005277A1 (en) | 2002-07-09 | 2003-07-09 | Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
Publications (1)
Publication Number | Publication Date |
---|---|
IL166108A0 true IL166108A0 (en) | 2006-01-15 |
Family
ID=30115739
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16610805A IL166108A0 (en) | 2002-07-09 | 2005-01-03 | Novel compounds pharmaceutical compositions containing same and methods of use for same |
IL190218A IL190218A0 (en) | 2002-07-09 | 2008-03-17 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL190218A IL190218A0 (en) | 2002-07-09 | 2008-03-17 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
Country Status (14)
Country | Link |
---|---|
US (2) | US7649012B2 (de) |
EP (3) | EP2386551A1 (de) |
JP (3) | JP2005533835A (de) |
KR (1) | KR101087559B1 (de) |
CN (2) | CN101602756B (de) |
AU (1) | AU2003265267B2 (de) |
BR (1) | BRPI0312649A2 (de) |
CA (2) | CA2491802C (de) |
EA (1) | EA013371B1 (de) |
HK (1) | HK1083835A1 (de) |
IL (2) | IL166108A0 (de) |
MX (1) | MXPA05000365A (de) |
SG (1) | SG169236A1 (de) |
WO (1) | WO2004005277A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1471906A4 (de) | 2002-02-08 | 2006-02-01 | Univ Johns Hopkins Med | Stimulation von cpt-1 als mittel zur gewichtsreduktion |
WO2004004712A1 (en) * | 2002-07-09 | 2004-01-15 | Fasgen, Llc | Methods of treating microbial infections in humans and animals |
EP2386551A1 (de) * | 2002-07-09 | 2011-11-16 | Fasgen Inc. | Neue Verbindungen, pharmazeutische Zusammensetzungen damit und Anwendungsverfahren dafür |
ZA200700024B (en) * | 2004-05-26 | 2008-06-25 | Fasgen Llc | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
WO2008017381A1 (de) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung |
WO2008057585A1 (en) * | 2006-11-08 | 2008-05-15 | Fasgen Llc | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
WO2008059214A1 (en) * | 2006-11-13 | 2008-05-22 | Astrazeneca Ab | Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
WO2009149066A1 (en) * | 2008-06-02 | 2009-12-10 | Fasgen, Inc. | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
AR072707A1 (es) | 2008-07-09 | 2010-09-15 | Sanofi Aventis | Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
US8729239B2 (en) | 2009-04-09 | 2014-05-20 | Nuclea Biotechnologies, Inc. | Antibodies against fatty acid synthase |
WO2011019498A1 (en) * | 2009-07-27 | 2011-02-17 | The Trustees Of Princeton University | Inhibition of glycerol-3-phosphate acyltransferase (gpat) and associated enzymes for treatment of viral infections |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
EP3159331A1 (de) | 2010-05-05 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Tetrazolone als fettsäuresynthasehemmer |
US8846666B2 (en) | 2011-03-08 | 2014-09-30 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
US9056851B2 (en) | 2011-03-25 | 2015-06-16 | The Research Foundation For The State University Of New York | Thiolactone antibiotics |
EP2567959B1 (de) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren |
CN104662028B (zh) * | 2012-06-25 | 2017-05-24 | 托马斯杰弗逊大学 | 对具有异常的脂肪生成信号的癌症进行治疗的组合物和方法 |
WO2014039769A1 (en) * | 2012-09-07 | 2014-03-13 | Janssen Pharmaceutica Nv | Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer |
PT2968316T (pt) | 2013-03-13 | 2019-10-29 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro |
EP3220901B1 (de) | 2014-11-20 | 2020-02-19 | VIB vzw | Mittel und verfahren zur behandlung von frühzeitigem morbus parkinson |
CN113382633A (zh) | 2018-10-29 | 2021-09-10 | 福马治疗股份有限公司 | (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式 |
CN114480521A (zh) * | 2020-11-13 | 2022-05-13 | 中国科学院青岛生物能源与过程研究所 | 一种三氮菌素c的制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3496187A (en) * | 1967-03-20 | 1970-02-17 | American Home Prod | N-(heterocyclyl)aconamides |
US3472878A (en) * | 1969-01-27 | 1969-10-14 | American Home Prod | N-(hydroxyaryl)aconamides |
JPS5859920A (ja) * | 1981-10-05 | 1983-04-09 | Chugai Pharmaceut Co Ltd | 生体防禦能賦活剤 |
US4565699A (en) * | 1983-07-18 | 1986-01-21 | The Upjohn Company | Composition of matter and process |
US4720503A (en) * | 1985-08-02 | 1988-01-19 | Merck & Co., Inc. | N-substituted fused-heterocyclic carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors |
CH667655A5 (de) * | 1986-09-24 | 1988-10-31 | Lonza Ag | Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen. |
US4753871A (en) * | 1986-12-12 | 1988-06-28 | Eastman Kodak Company | Cyan dye-forming couplers and photographic materials containing same |
WO1988004652A1 (en) * | 1986-12-17 | 1988-06-30 | Nippon Soda Co., Ltd. | Heterocyclic compounds having triketo skeleton |
US5759791A (en) * | 1989-01-17 | 1998-06-02 | The Johns Hopkins University | Cancer related antigen |
US5759837A (en) | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
US5665874A (en) * | 1989-01-17 | 1997-09-09 | John Hopkins University | Cancer related antigen |
US5679801A (en) * | 1991-04-12 | 1997-10-21 | American Home Products Corporation | Tetronic and thiotetronic acid derivatives as phospholipase A2 inhibitors |
US5614551A (en) | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
WO1996035664A1 (de) * | 1995-05-09 | 1996-11-14 | Bayer Aktiengesellschaft | Alkyl-dihalogenphenylsubstituierte ketoenole als schädlingsbekämpfungsmittel und herbizide |
US5981575A (en) | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
JPH10212284A (ja) * | 1996-11-27 | 1998-08-11 | Sagami Chem Res Center | テトロン酸−3−カルボン酸誘導体、その製造方法、製造中間体、抗がん剤、及び蛋白脱リン酸化酵素阻害剤 |
US6391912B1 (en) * | 1996-12-12 | 2002-05-21 | Bayer Aktiengesellschaft | Substituted phenylketoenols |
CO4970714A1 (es) * | 1997-09-05 | 2000-11-07 | Boehringer Mannheim Gmbh | Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
IT1315267B1 (it) * | 1999-12-23 | 2003-02-03 | Novuspharma Spa | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale |
GB0000131D0 (en) * | 2000-01-06 | 2000-02-23 | Univ Cardiff | Thiolactomycin analogues,compositions containing the same and uses thereof |
US6376682B1 (en) * | 2000-02-01 | 2002-04-23 | Takama System, Ltd. | Compound with α-glucosidase inhibiting action and method for producing the same |
JP2004528341A (ja) | 2001-05-02 | 2004-09-16 | ニューヨーク・ユニバーシティ | 脂肪酸合成酵素の阻害による色素形成の阻害 |
EP1471906A4 (de) * | 2002-02-08 | 2006-02-01 | Univ Johns Hopkins Med | Stimulation von cpt-1 als mittel zur gewichtsreduktion |
EP2386551A1 (de) * | 2002-07-09 | 2011-11-16 | Fasgen Inc. | Neue Verbindungen, pharmazeutische Zusammensetzungen damit und Anwendungsverfahren dafür |
WO2004004712A1 (en) | 2002-07-09 | 2004-01-15 | Fasgen, Llc | Methods of treating microbial infections in humans and animals |
US9690894B1 (en) | 2015-11-02 | 2017-06-27 | Altera Corporation | Safety features for high level design |
-
2003
- 2003-07-09 EP EP11164126A patent/EP2386551A1/de not_active Withdrawn
- 2003-07-09 CN CN200910203849.8A patent/CN101602756B/zh not_active Expired - Fee Related
- 2003-07-09 EA EA200500178A patent/EA013371B1/ru not_active IP Right Cessation
- 2003-07-09 SG SG200806632-6A patent/SG169236A1/en unknown
- 2003-07-09 CA CA2491802A patent/CA2491802C/en not_active Expired - Fee Related
- 2003-07-09 BR BRPI0312649A patent/BRPI0312649A2/pt not_active IP Right Cessation
- 2003-07-09 MX MXPA05000365A patent/MXPA05000365A/es active IP Right Grant
- 2003-07-09 WO PCT/US2003/021700 patent/WO2004005277A1/en active Application Filing
- 2003-07-09 EP EP11164123A patent/EP2386550A1/de not_active Withdrawn
- 2003-07-09 JP JP2004520132A patent/JP2005533835A/ja active Pending
- 2003-07-09 CA CA2767092A patent/CA2767092C/en not_active Expired - Fee Related
- 2003-07-09 KR KR1020057000382A patent/KR101087559B1/ko not_active IP Right Cessation
- 2003-07-09 EP EP03763470A patent/EP1539730A4/de not_active Withdrawn
- 2003-07-09 CN CNB038185563A patent/CN100513404C/zh not_active Expired - Fee Related
- 2003-07-09 US US10/520,505 patent/US7649012B2/en not_active Expired - Fee Related
- 2003-07-09 AU AU2003265267A patent/AU2003265267B2/en not_active Ceased
-
2005
- 2005-01-03 IL IL16610805A patent/IL166108A0/xx unknown
-
2006
- 2006-03-28 HK HK06103865.0A patent/HK1083835A1/xx not_active IP Right Cessation
-
2008
- 2008-03-17 IL IL190218A patent/IL190218A0/en unknown
-
2010
- 2010-01-13 US US12/686,691 patent/US20100120901A1/en not_active Abandoned
- 2010-10-08 JP JP2010228956A patent/JP2011037881A/ja active Pending
-
2013
- 2013-06-04 JP JP2013117677A patent/JP2013189464A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1539730A4 (de) | 2007-03-28 |
CA2491802A1 (en) | 2004-01-15 |
BRPI0312649A2 (pt) | 2017-05-16 |
US20060247302A1 (en) | 2006-11-02 |
CA2767092C (en) | 2013-10-15 |
AU2003265267A1 (en) | 2004-01-23 |
US7649012B2 (en) | 2010-01-19 |
JP2011037881A (ja) | 2011-02-24 |
CN1675192A (zh) | 2005-09-28 |
JP2013189464A (ja) | 2013-09-26 |
CA2767092A1 (en) | 2004-01-15 |
MXPA05000365A (es) | 2005-09-20 |
IL190218A0 (en) | 2008-11-03 |
EP2386551A1 (de) | 2011-11-16 |
WO2004005277A1 (en) | 2004-01-15 |
JP2005533835A (ja) | 2005-11-10 |
EP1539730A1 (de) | 2005-06-15 |
CN101602756B (zh) | 2014-11-12 |
EA200500178A1 (ru) | 2006-02-24 |
SG169236A1 (en) | 2011-03-30 |
EP2386550A1 (de) | 2011-11-16 |
CN101602756A (zh) | 2009-12-16 |
KR101087559B1 (ko) | 2011-11-29 |
US20100120901A1 (en) | 2010-05-13 |
KR20060002007A (ko) | 2006-01-06 |
HK1083835A1 (en) | 2006-07-14 |
AU2003265267B2 (en) | 2010-03-11 |
CA2491802C (en) | 2012-04-10 |
EA013371B1 (ru) | 2010-04-30 |
CN100513404C (zh) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
HK1093975A1 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
IL164987A0 (en) | Proline derivatives and pharmaceutical compositions containing | |
IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
HUP0401711A3 (en) | N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them | |
IL164185A0 (en) | Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives | |
HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
IL174128A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
HUP0303724A3 (en) | Chemokine receptors inhibitor bipiperidinyl-derivatives and pharmaceutical compositions containing them and process for preparation of the compounds | |
HUP0303193A3 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them | |
IL174249A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
EP1569915A4 (de) | Spirocyclische harnstoffe,zusammensetzungen, die diese verbindungen enthalten, und anwendungsverfahren | |
IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
AU2003222921A8 (en) | Novel perindopril salt and pharmaceutical compositions containing same | |
SI1664050T1 (sl) | Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te | |
IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
PL367128A1 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
PL361518A1 (en) | Application of substance and pharmaceutical composition | |
IL165902A0 (en) | Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same | |
HUP0401862A3 (en) | Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them |